<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

First-line usage of daratumumab, lenalidomide, dexamethasone (DRd) combination in a case of castleman disease variant of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome (CD-POEMS)

Simple item page
dc.authorid0000-0001-9636-4113
dc.authorid0000-0003-1508-2822
dc.authorid0000-0001-6826-7818
dc.contributor.authorSevindik, Ömür Gökmen
dc.contributor.authorMutlu, Yaşa Gül
dc.contributor.authorBalık Aydın, Berrin
dc.contributor.authorSerin, İstemi
dc.date.accessioned2022-07-06T05:38:56Z
dc.date.available2022-07-06T05:38:56Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractPolyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome (POEMS) is a rare paraneoplastic syndrome of an underlying plasma cell disorder (PCD).1 Castleman disease (CD), itself, can also cause symptoms or signs of polyneuropathy, volume overload, cytokine release, but only those with peripheral neuropathy and a plasma cell clone can be classified as classical POEMS.
dc.identifier.citationSevindik, Ö. G., Mutlu, Y. G., Balık Aydın, B. ve Serin, İ. (2022). First-line usage of daratumumab, lenalidomide, dexamethasone (DRd) combination in a case of castleman disease variant of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome (CD-POEMS). HemaSphere, 6(7). http://doi.org/10.1097/HS9.0000000000000728
dc.identifier.doi10.1097/HS9.0000000000000728
dc.identifier.issn2572-9241
dc.identifier.issue7
dc.identifier.pmid35747589
dc.identifier.urihttp://doi.org/10.1097/HS9.0000000000000728
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9562
dc.identifier.volume6
dc.identifier.wos000812385100001en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.institutionauthorSevindik, Ömür Gökmen
dc.institutionauthorMutlu, Yaşa Gül
dc.institutionauthorBalık Aydın, Berrin
dc.language.isoen
dc.publisherLippincot Williams & Wilkins
dc.relation.ispartofHemaSphereen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectSkin Changes Syndrome (CD-POEMS)
dc.subjectEndocrinopathy
dc.subjectOrganomegaly
dc.subjectMonoclonal Gammopathy
dc.subjectCase of Castleman Disease
dc.titleFirst-line usage of daratumumab, lenalidomide, dexamethasone (DRd) combination in a case of castleman disease variant of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome (CD-POEMS)
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Sevindik-Omur-2022.pdf
Size:
484.96 KB
Format:
Adobe Portable Document Format
Description:
Tam Metin / Full Text
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu